Thomas Clozel is the founder of Owkin. Owkin has raised $308M in total funding. Latest round: Series C. Backed by Sanofi, Google Ventures, Bpifrance.
Thomas Clozel is the Co-founder and CEO of Owkin, a French-American TechBio company. He transitioned from his previous role as an assistant professor of clinical onco-hematology in Paris and researcher at Weill Cornell to co-found Owkin in 2016 alongside AI researcher Gilles Wainrib. The company utilizes AI and federated learning to accelerate drug discovery, develop diagnostics, and optimize clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library